Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy

10 Jul 2023

Abstract excerpt

Background: Diabetic nephropathy (DN), which is the main cause of renal failure in end-stage renal disease, is becoming a common chronic renal disease worldwide. Mendelian randomization (MR) is a genetic tool that is widely used to minimize confounding and reverse causation when identifying the causal effects of complex traits. In this study, we conducted an integrated multiple microarray analysis and large-scale...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes
Share to GDF15 and Related Biomarkers
Share to Genetic Associations and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37492198
DOI: 10.3389/fendo.2023.1191768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathyPMID 37492198Read ↗

Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathySemantic proximity Read ↗

Identification of diagnostic biomarkers for diabetes nephropathy by multi-chip integrated bioinformatics combining machine-learning strategies and mendelian randomizationSemantic proximity Read ↗

Comprehensive Druggable Genome-Wide Mendelian Randomization Reveals Therapeutic Targets for Kidney DiseasesSemantic proximity Read ↗

The unique molecular mechanism of diabetic nephropathy: a bioinformatics analysis of over 250 microarray datasetsSemantic proximity Read ↗

Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysisSemantic proximity Read ↗

Integrative analyses of biomarkers and pathways for diabetic nephropathySemantic proximity Read ↗

Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.Semantic proximity Read ↗

Unraveling the Molecular Nexus between Ankylosing Spondylitis and IgA Nephropathy: Insights from Mendelian Randomization and Bioinformatics Analysis.Semantic proximity Read ↗

Transcriptome analysis combined with Mendelian randomization screening for biomarkers causally associated with diabetic retinopathySemantic proximity Read ↗

Integrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis.Semantic proximity Read ↗

Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization studySemantic proximity Read ↗

Identification of biomarkers in diabetic neuropathy: a Mendelian randomization and bioinformatics analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.